Oxaliplatin plus irinotecan compared with irinotecan alone as second-line treatment after single-agent fluoropyrimidine therapy for metastatic colorectal carcinoma.
暂无分享,去创建一个
W. Miller | D. Haller | G. Bodoky | M. Rothenberg | P. Koralewski | A. Wong | C. Garay | N. Habboubi | L. Olivatto | Luis O. Olivatto | Nassir Habboubi